Annual Shareholders Equity
$599.50 M
+$48.57 M+8.82%
31 December 2023
Summary:
Verve Therapeutics annual stockholders equity is currently $599.50 million, with the most recent change of +$48.57 million (+8.82%) on 31 December 2023. During the last 3 years, it has risen by +$663.41 million (+1038.06%). VERV annual shareholders equity is now at all-time high.VERV Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$508.55 M
-$37.54 M-6.87%
30 September 2024
Summary:
Verve Therapeutics quarterly stockholders equity is currently $508.55 million, with the most recent change of -$37.54 million (-6.87%) on 30 September 2024. Over the past year, it has increased by +$48.18 million (+10.47%). VERV quarterly shareholders equity is now -15.17% below its all-time high of $599.50 million, reached on 31 December 2023.VERV Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VERV Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +8.8% | +10.5% |
| 3 y3 years | +1038.1% | +32.1% |
| 5 y5 years | - | - |
VERV Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +1038.1% | -15.2% | +71.6% |
| 5 y | 5 years | at high | +1038.1% | -15.2% | +765.4% |
| alltime | all time | at high | +1038.1% | -15.2% | +765.4% |
Verve Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $508.55 M(-6.9%) |
| June 2024 | - | $546.09 M(-6.3%) |
| Mar 2024 | - | $583.07 M(-2.7%) |
| Dec 2023 | $599.50 M(+8.8%) | $599.50 M(+30.2%) |
| Sept 2023 | - | $460.37 M(-1.0%) |
| June 2023 | - | $465.22 M(-8.7%) |
| Mar 2023 | - | $509.48 M(-7.5%) |
| Dec 2022 | $550.93 M | $550.93 M(+0.5%) |
| Sept 2022 | - | $547.94 M(+84.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $296.33 M(-10.6%) |
| Mar 2022 | - | $331.39 M(-7.3%) |
| Dec 2021 | $357.35 M(-659.2%) | $357.35 M(-7.2%) |
| Sept 2021 | - | $384.94 M(-5.0%) |
| June 2021 | - | $405.40 M(-630.4%) |
| Mar 2021 | - | -$76.43 M(+19.6%) |
| Dec 2020 | -$63.91 M(+226.9%) | - |
| Dec 2020 | - | -$63.91 M |
| Dec 2019 | -$19.55 M | - |
FAQ
- What is Verve Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Verve Therapeutics?
- What is Verve Therapeutics annual shareholders equity year-on-year change?
- What is Verve Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Verve Therapeutics?
- What is Verve Therapeutics quarterly shareholders equity year-on-year change?
What is Verve Therapeutics annual stockholders equity?
The current annual shareholders equity of VERV is $599.50 M
What is the all time high annual shareholders equity for Verve Therapeutics?
Verve Therapeutics all-time high annual stockholders equity is $599.50 M
What is Verve Therapeutics annual shareholders equity year-on-year change?
Over the past year, VERV annual stockholders equity has changed by +$48.57 M (+8.82%)
What is Verve Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of VERV is $508.55 M
What is the all time high quarterly shareholders equity for Verve Therapeutics?
Verve Therapeutics all-time high quarterly stockholders equity is $599.50 M
What is Verve Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, VERV quarterly stockholders equity has changed by +$48.18 M (+10.47%)